Attention!

What is the drug AVIANDR®

AVIANDR® is an original drug for the treatment of anxiety conditions, including after coronavirus infection (COVID-19): in patients with a leading complaint of anxiety, with a change in mood background, short temper and irritability; in patients with a stress reaction and impaired adaptation, mild to moderate severity.

Dosage form

Film-coated tablets.

Round biconvex tablets, film-coated in white or almost white color. On a cross-section, the tablet core is white or almost white in color.

Indications for use

AVIANDR® is indicated for use in adults over 18 years of age for the treatment of:

- Generalized anxiety disorder.

- For anxiety states after a coronavirus infection (COVID-19): in patients with a stress reaction and adaptation disorders, mild to moderate severity.

Efficacy and safety studies

The results of multicenter randomized placebo-controlled trials showed a rapid reduction in anxiety symptoms-from the first week of taking the drug, while patients did not experience drowsiness and other side effects characteristic of traditional therapy, which is important for patients ' compliance with the prescribed regimen (adherence to therapy). Often, anxiety states are accompanied by an increased heart rate, high fatigue, weakness, increased blood pressure, sweating, abdominal pain, the drug AVIANDR® reduced the manifestation of such symptoms.

Completed clinical trials

Phase Ia-Ib: assessment of single and multiple dose tolerability

Phase II: Generalized anxiety disorder

Phase III: Generalized anxiety disorder, adaptation disorder

Post-registration effectiveness and safety studies